Ramoz LL, Patel-Shori NM. Recent changes in pregnancy and lactation labeling: retirement of risk categories. Pharmacotherapy. 2014;34(4):389-395.
- U.S. Food and Drug Administration. Pregnancy and lactation labeling (drugs) final rule. December 3, 2014. Accessed December 1, 2022. www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-drugs-final-rule
Committee on Practice Bulletins–Obstetrics. ACOG practice bulletin no. 189: nausea and vomiting of pregnancy. Obstet Gynecol. 2018;131(1):e15-e30.
Etwel F, Faught LH, Rieder MJ, et al. The risk of adverse pregnancy outcome after first trimester exposure to H1 antihistamines: a systematic review and meta-analysis. Drug Saf. 2017;40(2):121-132.
Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med. 2002;11(3):146-152.
Kennedy DA, Lupattelli A, Koren G, et al. Herbal medicine use in pregnancy: results of a multinational study. BMC Complement Altern Med. 2013;13:355.
Viljoen E, Visser J, Koen N, et al. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J. 2014;13:20.
Muñoz Balbontín Y, Stewart D, Shetty A, et al. Herbal medicinal product use during pregnancy and the postnatal period: a systematic review. Obstet Gynecol. 2019;133(5):920-932.
Sharifzadeh F, Kashanian M, Koohpayehzadeh J, et al. A comparison between the effects of ginger, pyridoxine (vitamin B6) and placebo for the treatment of the first trimester nausea and vomiting of pregnancy (NVP). J Matern Fetal Neonatal Med. 2018;31(19):2509-2514.
Altuwaijri M. Evidence-based treatment recommendations for gastroesophageal reflux disease during pregnancy: a review. Medicine (Baltimore). 2022;101(35):e30487.
Matok I, Gorodischer R, Koren G, et al. The safety of H(2)-blockers use during pregnancy. J Clin Pharmacol. 2010;50(1):81-87.
Li CM, Zhernakova A, Engstrand L, et al. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy. Aliment Pharmacol Ther. 2020;51(4):410-420.
Merative Micromedex. Accessed March 30, 2023. https://www.micromedexsolutions.com/
Body C, Christie JA. Gastrointestinal diseases in pregnancy: nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea. Gastroenterol Clin North Am. 2016;45(2):267-283.
Sheyholislami H, Connor KL. Are probiotics and prebiotics safe for use during pregnancy and lactation? A systematic review and meta-analysis. Nutrients. 2021;13(7):2382.
de Milliano I, Tabbers MM, van der Post JA, et al. Is a multispecies probiotic mixture effective in constipation during pregnancy? ‘A pilot study’. Nutr J. 2012;11:80.
Poskus T, Sabonyte-Balsaitiene Z, Jakubauskiene L, et al. Preventing hemorrhoids during pregnancy: a multicenter, randomized clinical trial. BMC Pregnancy Childbirth. 2022;22(1):374.
Chi CC, Wang SH, Wojnarowska F, et al. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2015(10):CD007346.
Kestřánek J. Hemorrhoid management in women: the role of tribenoside + lidocaine. Drugs Context. 2019;8:212602.
Ebrahimi N, Vohra S, Gedeon C, et al. The fetal safety of hydrocortisone-pramoxine (Proctofoam-HC) for the treatment of hemorrhoids in late pregnancy [published correction appears in J Obstet Gynaecol Can. 2011; 33(5): 436]. J Obstet Gynaecol Can. 2011;33(2):153-158.
Vaughan Jones S, Ambros-Rudolph C, Nelson-Piercy C. Skin disease in pregnancy. BMJ. 2014;348:g3489.
Ly S, Kamal K, Manjaly P, et al. Treatment of acne vulgaris during pregnancy and lactation: a narrative review. Dermatol Ther (Heidelb). 2023;13(1):115-130.
Chien AL, Qi J, Rainer B, et al. Treatment of acne in pregnancy. J Am Board Fam Med. 2016;29(2):254-262.
Lipson AH, Collins F, Webster WS. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet. 1993;341(8856):1352-1353.
Han G, Wu JJ, Del Rosso JQ. Use of topical tazarotene for the treatment of acne vulgaris in pregnancy: a literature review. J Clin Aesthet Dermatol. 2020;13(9):E59-E65.
Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116-132.
Pilmis B, Jullien V, Sobel J, et al. Antifungal drugs during pregnancy: an updated review. J Antimicrob Chemother. 2015;70(1):14-22.
Torloni MR, Cordioli E, Zamith MM, et al. Reversible constriction of the fetal ductus arteriosus after maternal use of topical diclofenac and methyl salicylate. Ultrasound Obstet Gynecol. 2006;27(2):227-229.
Le Duc K, Gilliot S, Baudelet JB, et al. Case report: persistent pulmonary hypertension of the newborn and narrowing of the ductus arteriosus after topical use of non-steroidal anti-inflammatory during pregnancy. Front Pharmacol. 2021;12:756056.
Caparroz FA, Gregorio LL, Bongiovanni G, et al. Rhinitis and pregnancy: literature review. Braz J Otorhinolaryngol. 2016;82(1):105-111.
Garavello W, Somigliana E, Acaia B, et al. Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. Int Arch Allergy Immunol. 2010;151(2):137-141.
ACOG Committee on Clinical Practice Guidelines–Obstetrics. Headaches in pregnancy and postpartum: ACOG clinical practice guideline no. 3 [published correction appears in Obstet Gynecol. 2022; 140(2): 344]. Obstet Gynecol. 2022;139(5):944-972.
Barańska A, Kanadys W, Wdowiak A, et al. Effects of prenatal paracetamol exposure on the development of asthma and wheezing in childhood: a systematic review and meta-analysis. J Clin Med. 2023;12(5):1832.
Ji Y, Azuine RE, Zhang Y, et al. Association of cord plasma biomarkers of in utero acetaminophen exposure with risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in childhood. JAMA Psychiatry. 2020;77(2):180-189.
Ystrom E, Gustavson K, Brandlistuen RE, et al. Prenatal exposure to acetaminophen and risk of ADHD. Pediatrics. 2017;140(5):e20163840.
Masarwa R, Levine H, Gorelik E, et al. Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: a systematic review, meta-analysis, and meta-regression analysis of cohort studies. Am J Epidemiol. 2018;187(8):1817-1827.
Patel R, Sushko K, van den Anker J, et al. Long-term safety of prenatal and neonatal exposure to paracetamol: a systematic review. Int J Environ Res Public Health. 2022;19(4):2128.
Bauer AZ, Swan SH, Kriebel D, et al. Paracetamol use during pregnancy–a call for precautionary action. Nat Rev Endocrinol. 2021;17(12):757-766.
- American College of Obstetricians and Gynecologists. ACOG response to consensus statement on paracetamol use during pregnancy. September 29, 2021. Accessed December 1, 2022. https://www.acog.org/news/news-articles/2021/09/response-to-consensus-statement-on-paracetamol-use-during-pregnancy
Li J, Zhao H, Song JM, et al. A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy. Int J Gynaecol Obstet. 2015;130(2):116-122.
Mazza GR, Solorio C, Stek AM, et al. Assessing the efficacy of magnesium oxide and riboflavin as preventative treatment of migraines in pregnancy [published online December 10, 2022]. Arch Gynecol Obstet. Accessed January 8, 2023. https://link.springer.com/article/10.1007/s00404-022-06872-y
Interrante JD, Ailes EC, Lind JN, et al.; National Birth Defects Prevention Study. Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997–2011. Ann Epidemiol. 2017;27(10):645-653.e2.
U.S. Food and Drug Administration. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. Updated September 1, 2022. Accessed December 15, 2022. https://www.fda.gov/media/142967/download
Koren G, Florescu A, Costei AM, et al. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006;40(5):824-829.
Chaudhry SK, Susser LC. Considerations in treating insomnia during pregnancy: a literature review. Psychosomatics. 2018;59(4):341-348.
Khazaie H, Ghadami MR, Knight DC, et al. Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial. Psychiatry Res. 2013;210(3):901-905.
Vine T, Brown GM, Frey BN. Melatonin use during pregnancy and lactation: a scoping review of human studies. Braz J Psychiatry. 2022;44(3):342-348.
Wang SM, Dezinno P, Maranets I, et al. Low back pain during pregnancy: prevalence, risk factors, and outcomes. Obstet Gynecol. 2004;104(1):65-70.
Lal D, Jategaonkar AA, Borish L, et al. Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations. Rhinology. 2016;54(2):99-104.
Ellegård EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol Allied Sci. 2001;26(5):394-400.
Werler MM. Teratogen update: pseudoephedrine. Birth Defects Res A Clin Mol Teratol. 2006;76(6):445-452.
Yau WP, Mitchell AA, Lin KJ, et al. Use of decongestants during pregnancy and the risk of birth defects. Am J Epidemiol. 2013;178(2):198-208.
Einarson A, Lyszkiewicz D, Koren G. The safety of dextromethorphan in pregnancy: results of a controlled study. Chest. 2001;119(2):466-469.
Silva R, Lee JH, Tweed E, et al. Clinical inquiries. Is guaifenesin safe during pregnancy?. J Fam Pract. 2007;56(8):669-670.
Liddle SD, Pennick V. Interventions for preventing and treating low-back and pelvic pain during pregnancy. Cochrane Database Syst Rev. 2015(9):CD001139.
Black E, Khor KE, Kennedy D, et al. Medication use and pain management in pregnancy: a critical review. Pain Pract. 2019;19(8):875-899.
Davidson KW, Barry MJ, Mangione CM, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(12):1186-1191.
ACOG committee opinion no. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44-e52.
Henderson JT, Vesco KK, Senger CA, et al. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality. Evidence synthesis no. 205. Agency for Healthcare Research and Quality (US); September 2021. Accessed November 11, 2022. https://www.ncbi.nlm.nih.gov/books/NBK574449/
Grab D, Paulus WE, Erdmann M, et al. Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. Ultrasound Obstet Gynecol. 2000;15(1):19-27.
Shi FP, Huang YY, Dai QQ, et al. Maternal common cold or fever during pregnancy and the risk of orofacial clefts in the offspring: a systematic review and meta-analysis. Cleft Palate Craniofac J. 2023;60(4):446-453.
Antoun S, Ellul P, Peyre H, et al. Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis. Mol Autism. 2021;12(1):60.
Warland J, Dorrian J, Morrison JL, et al. Maternal sleep during pregnancy and poor fetal outcomes: a scoping review of the literature with meta-analysis. Sleep Med Rev. 2018;41:197-219.
Heitmann K, Havnen GC, Holst L, et al. Pregnancy outcomes after prenatal exposure to echinacea: the Norwegian Mother and Child Cohort Study. Eur J Clin Pharmacol. 2016;72(5):623-630.
Bowman R, Taylor J, Muggleton S, et al. Biophysical effects, safety and efficacy of raspberry leaf use in pregnancy: a systematic integrative review. BMC Complement Med Ther. 2021;21(1):56.
NatMed: A trchealthcare brand. Accessed December 11, 2022. https://naturalmedicines.therapeuticresearch.com
Servey J, Chang J. Over-the-counter medications in pregnancy [published correction appears in Am Fam Physician. 2015; 92(5): 332]. Am Fam Physician. 2014;90(8):548-555.
Black RA, Hill DA. Over-the-counter medications in pregnancy. Am Fam Physician. 2003;67(12):2517-2524.